[0JBU] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[0JBU] Intellia Therapeutics, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -13.26%
YoY- -58.04%
Quarter Report
0JBU's Result
0JBU's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 9,111 11,992 13,266 7,204 22,220 10,616 7,408 3.50%
PBT -135,712 -122,224 -113,229 -71,644 -27,840 -23,634 -22,702 34.68%
Tax 0 0 0 0 0 0 0 -
NP -135,712 -122,224 -113,229 -71,644 -27,840 -23,634 -22,702 34.68%
Tax Rate - - - - - - - -
Total Cost 144,823 134,216 126,495 78,848 50,060 34,250 30,110 29.89%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -1,489.54 -1,019.21 -853.53 -994.50 -125.29 -222.63 -306.45 30.12%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -1.34 -1.38 -1.49 -0.97 -0.47 -0.49 -0.53 16.70%
EPS Diluted -1.34 -1.38 -1.49 -0.97 -0.47 -0.49 -0.53 16.70%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.